A review on Iguratimod: Bridging Hope for Arthritis Patients through the Dual Power of Immunomodulation and Anti-inflammation
Nikita Gupta, Sana Begum, Varda Farooqui, Summaiya Afreen & Pranitha Avunoori · Asian Journal of Immunology · 2024
Iguratimod is a small novel compound considered as a disease-modifying anti-rheumatic drug (DMARD), which exhibits anti-inflammatory and immunomodulatory effects. Iguratimod acts directly on B cells by inhibiting the production of inflammatory cytokines (tumor necrosis factor-α,...
Open access
Research Article
10.9734/aji/2024/v7i1132